Clinical Trials Browser

Phase 1/2 × Breast Neoplasms × Immunotherapy, Adoptive × Clear all

NCT04609215 2022-04-20

ImmunoBreast - A Phase Ib Study

Phase 1/2 Unknown

Breast Neoplasms, Triple Negative Breast Neoplasms